Cargando…

Comparative evaluation of the clinical laboratory-based Intermountain risk score with the Charlson and Elixhauser comorbidity indices for mortality prediction

BACKGROUND: The Charlson and Elixhauser comorbidity indices are mortality predictors often used in clinical, administrative, and research applications. The Intermountain Mortality Risk Scores (IMRS) are validated mortality predictors that use all factors from the complete blood count and basic metab...

Descripción completa

Detalles Bibliográficos
Autores principales: Snow, Gregory L., Bledsoe, Joseph R., Butler, Allison, Wilson, Emily L., Rea, Susan, Majercik, Sarah, Anderson, Jeffrey L., Horne, Benjamin D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7241706/
https://www.ncbi.nlm.nih.gov/pubmed/32437416
http://dx.doi.org/10.1371/journal.pone.0233495
_version_ 1783537106421809152
author Snow, Gregory L.
Bledsoe, Joseph R.
Butler, Allison
Wilson, Emily L.
Rea, Susan
Majercik, Sarah
Anderson, Jeffrey L.
Horne, Benjamin D.
author_facet Snow, Gregory L.
Bledsoe, Joseph R.
Butler, Allison
Wilson, Emily L.
Rea, Susan
Majercik, Sarah
Anderson, Jeffrey L.
Horne, Benjamin D.
author_sort Snow, Gregory L.
collection PubMed
description BACKGROUND: The Charlson and Elixhauser comorbidity indices are mortality predictors often used in clinical, administrative, and research applications. The Intermountain Mortality Risk Scores (IMRS) are validated mortality predictors that use all factors from the complete blood count and basic metabolic profile. How IMRS, Charlson, and Elixhauser relate to each other is unknown. METHODS: All inpatient admissions except obstetric patients at Intermountain Healthcare’s 21 adult care hospitals from 2010–2014 (N = 197,680) were examined in a observational cohort study. The most recent admission was a patient’s index encounter. Follow-up to 2018 used hospital death records, Utah death certificates, and the Social Security death master file. Three Charlson versions, 8 Elixhauser versions, and 3 IMRS formulations were evaluated in Cox regression and the one of each that was most predictive was used in dual risk score mortality analyses (in-hospital, 30-day, 1-year, and 5-year mortality). RESULTS: Indices with the strongest mortality associations and selected for dual score study were the age-adjusted Charlson, the van Walraven version of the acute Elixhauser, and the 1-year IMRS. For in-hospital mortality, Charlson (c = 0.719; HR = 4.75, 95% CI = 4.45, 5.07), Elixhauser (c = 0.783; HR = 5.79, CI = 5.41, 6.19), and IMRS (c = 0.821; HR = 17.95, CI = 15.90, 20.26) were significant predictors (p<0.001) in univariate analyses. Dual score analysis of Charlson (HR = 1.79, CI = 1.66, 1.92) with IMRS (HR = 13.10, CI = 11.53, 14.87) and of Elixhauser (HR = 3.00, CI = 2.80, 3.21) with IMRS (HR = 11.42, CI = 10.09, 12.92) found significance for both scores in each model. Results were similar for 30-day, 1-year, and 5-year mortality. CONCLUSIONS: IMRS provided the strongest ability to predict mortality, adding to and attenuating the predictive ability of the Charlson and Elixhauser indices whose mortality associations remained statistically significant. IMRS uses common, standardized, objective laboratory data and should be further evaluated for integration into mortality risk evaluations.
format Online
Article
Text
id pubmed-7241706
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-72417062020-06-08 Comparative evaluation of the clinical laboratory-based Intermountain risk score with the Charlson and Elixhauser comorbidity indices for mortality prediction Snow, Gregory L. Bledsoe, Joseph R. Butler, Allison Wilson, Emily L. Rea, Susan Majercik, Sarah Anderson, Jeffrey L. Horne, Benjamin D. PLoS One Research Article BACKGROUND: The Charlson and Elixhauser comorbidity indices are mortality predictors often used in clinical, administrative, and research applications. The Intermountain Mortality Risk Scores (IMRS) are validated mortality predictors that use all factors from the complete blood count and basic metabolic profile. How IMRS, Charlson, and Elixhauser relate to each other is unknown. METHODS: All inpatient admissions except obstetric patients at Intermountain Healthcare’s 21 adult care hospitals from 2010–2014 (N = 197,680) were examined in a observational cohort study. The most recent admission was a patient’s index encounter. Follow-up to 2018 used hospital death records, Utah death certificates, and the Social Security death master file. Three Charlson versions, 8 Elixhauser versions, and 3 IMRS formulations were evaluated in Cox regression and the one of each that was most predictive was used in dual risk score mortality analyses (in-hospital, 30-day, 1-year, and 5-year mortality). RESULTS: Indices with the strongest mortality associations and selected for dual score study were the age-adjusted Charlson, the van Walraven version of the acute Elixhauser, and the 1-year IMRS. For in-hospital mortality, Charlson (c = 0.719; HR = 4.75, 95% CI = 4.45, 5.07), Elixhauser (c = 0.783; HR = 5.79, CI = 5.41, 6.19), and IMRS (c = 0.821; HR = 17.95, CI = 15.90, 20.26) were significant predictors (p<0.001) in univariate analyses. Dual score analysis of Charlson (HR = 1.79, CI = 1.66, 1.92) with IMRS (HR = 13.10, CI = 11.53, 14.87) and of Elixhauser (HR = 3.00, CI = 2.80, 3.21) with IMRS (HR = 11.42, CI = 10.09, 12.92) found significance for both scores in each model. Results were similar for 30-day, 1-year, and 5-year mortality. CONCLUSIONS: IMRS provided the strongest ability to predict mortality, adding to and attenuating the predictive ability of the Charlson and Elixhauser indices whose mortality associations remained statistically significant. IMRS uses common, standardized, objective laboratory data and should be further evaluated for integration into mortality risk evaluations. Public Library of Science 2020-05-21 /pmc/articles/PMC7241706/ /pubmed/32437416 http://dx.doi.org/10.1371/journal.pone.0233495 Text en © 2020 Snow et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Snow, Gregory L.
Bledsoe, Joseph R.
Butler, Allison
Wilson, Emily L.
Rea, Susan
Majercik, Sarah
Anderson, Jeffrey L.
Horne, Benjamin D.
Comparative evaluation of the clinical laboratory-based Intermountain risk score with the Charlson and Elixhauser comorbidity indices for mortality prediction
title Comparative evaluation of the clinical laboratory-based Intermountain risk score with the Charlson and Elixhauser comorbidity indices for mortality prediction
title_full Comparative evaluation of the clinical laboratory-based Intermountain risk score with the Charlson and Elixhauser comorbidity indices for mortality prediction
title_fullStr Comparative evaluation of the clinical laboratory-based Intermountain risk score with the Charlson and Elixhauser comorbidity indices for mortality prediction
title_full_unstemmed Comparative evaluation of the clinical laboratory-based Intermountain risk score with the Charlson and Elixhauser comorbidity indices for mortality prediction
title_short Comparative evaluation of the clinical laboratory-based Intermountain risk score with the Charlson and Elixhauser comorbidity indices for mortality prediction
title_sort comparative evaluation of the clinical laboratory-based intermountain risk score with the charlson and elixhauser comorbidity indices for mortality prediction
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7241706/
https://www.ncbi.nlm.nih.gov/pubmed/32437416
http://dx.doi.org/10.1371/journal.pone.0233495
work_keys_str_mv AT snowgregoryl comparativeevaluationoftheclinicallaboratorybasedintermountainriskscorewiththecharlsonandelixhausercomorbidityindicesformortalityprediction
AT bledsoejosephr comparativeevaluationoftheclinicallaboratorybasedintermountainriskscorewiththecharlsonandelixhausercomorbidityindicesformortalityprediction
AT butlerallison comparativeevaluationoftheclinicallaboratorybasedintermountainriskscorewiththecharlsonandelixhausercomorbidityindicesformortalityprediction
AT wilsonemilyl comparativeevaluationoftheclinicallaboratorybasedintermountainriskscorewiththecharlsonandelixhausercomorbidityindicesformortalityprediction
AT reasusan comparativeevaluationoftheclinicallaboratorybasedintermountainriskscorewiththecharlsonandelixhausercomorbidityindicesformortalityprediction
AT majerciksarah comparativeevaluationoftheclinicallaboratorybasedintermountainriskscorewiththecharlsonandelixhausercomorbidityindicesformortalityprediction
AT andersonjeffreyl comparativeevaluationoftheclinicallaboratorybasedintermountainriskscorewiththecharlsonandelixhausercomorbidityindicesformortalityprediction
AT hornebenjamind comparativeevaluationoftheclinicallaboratorybasedintermountainriskscorewiththecharlsonandelixhausercomorbidityindicesformortalityprediction